Vitalik Buterin Criticizes Celebrity Meme Coins, Advocates for Purposeful "Financialization"

Ethereum co-founder Vitalik Buterin has voiced strong criticism against the recent trend of celebrity-backed meme coins, emphasizing the need for more meaningful and impactful projects in the cryptocurrency space. Through a series of tweets and a comprehensive blog post, Buterin outlined his dissatisfaction with celebrity meme coins, which he believes lack purpose and longevity. He...

Read More

Tether’s Paolo Ardoino Cautions Against Fake Airdrop Emails Amid Crypto Mailing List Compromise

An alarming report from Tether’s CEO, Paolo Ardoino, confirmed that a major vendor managing mailing lists for various crypto companies had been compromised. This breach has potentially exposed sensitive information, leading to fraudulent emails suggesting crypto-airdrops. As multiple thought leaders have claimed, this breach poses a significant threat to security and trust within the crypto...

Read More

Yen Falls As European Shares Gain

The Japanese yen weakened against other major currencies in the European session on Wednesday, as investors looked ahead to Thursday\'s ECB meeting and the release of U.S. labor market data on Friday for directional cues. The European Central Bank is expected to ease borrowing costs by 25 basis points from the present record levels of...

Read More

UK Authorities Begin Proceedings Against Six Exchanges Over 2019 Delisting of Bitcoin SV (BSV)

The United Kingdom’s Competition Appeal Tribunal has initiated proceedings against six major cryptocurrency exchanges over their decision to delist Bitcoin SV (BSV) in 2019. The case, brought forward by plaintiffs seeking $9 billion in damages for missed opportunities, indicates more red lights on the ongoing legal complexities and significant financial stakes within the crypto industry....

Read More

I-Mab Inks Partnership With Bristol Myers Squibb To Evaluate Givastomig In Combination Study

Biotech company I-Mab (IMAB) announced Wednesday that it has entered into a clinical trial collaboration and supply agreement with Bristol Myers Squibb (BMY). The collaboration will evaluate the combination of givastomig, an investigational Claudin 18.2 x 4-1BB bispecific antibody jointly developed by I-Mab and ABL Bio, with Bristol Myers Squibb\'s immune checkpoint inhibitor, nivolumab, and...

Read More

DAX Climbs After PMI Data

German stocks advanced on Monday after a survey showed business conditions in the German manufacturing sector steadied further in May. The HCOB final Purchasing Managers\' Index (PMI) for German manufacturing rose to 45.4 from 42.5 in April, confirming a preliminary flash estimate as output and new orders declined at a much slower pace than the...

Read More